Neuroprotective effect of liraglutide in an experimental mouse model of multiple sclerosis: role of AMPK/SIRT1 signaling and NLRP3 inflammasome

The heterogeneous nature of multiple sclerosis (MS) and the unavailability of treatments addressing its intricate network and reversing the disease state is yet an area that needs to be elucidated. Liraglutide, a glucagon-like peptide-1 analogue, recently exhibited intriguing potential neuroprotecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Ammar, Reham A., Mohamed, Ahmed F., Kamal, Mohamed M., Safar, Marwa M., Abdelkader, Noha F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135867/
https://www.ncbi.nlm.nih.gov/pubmed/35364735
http://dx.doi.org/10.1007/s10787-022-00956-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135867/
https://www.ncbi.nlm.nih.gov/pubmed/35364735
http://dx.doi.org/10.1007/s10787-022-00956-6

Ejemplares similares